1. Introduction {#s0005}
===============

Alzheimer\'s disease (AD) is the most common type of dementia, affecting 1 in 8 people over age 65 in the U.S. alone ([@bb0005]). Its prevalence is predicted to more than double in the next 40 years ([@bb0010]). It is important to identify individuals most likely to develop AD, so that those at greater risk can be treated earlier. One high-risk group consists of people with mild cognitive impairment (MCI) --- a transitional stage between normal aging and AD. People with MCI convert to AD at a rate of about 10--15% per year ([@bb0015; @bb0020]). In addition to the more widely-accepted measures from anatomical MRI, PET, and CSF measures of pathology, one major neuroimaging study of AD -- the Alzheimer\'s Disease Neuroimaging Initiative (ADNI) -- recently incorporated additional neuroimaging techniques including diffusion tensor imaging (DTI) ([@bb0025; @bb0030; @bb0035]). DTI is a variant of MRI that measures the diffusion of water molecules in brain tissue. Here we set out to assess which standard DTI measures may best identify neuroanatomical differences between AD, MCI, and normal aging. In the end, DTI offers a range of measures that might be sensitive to pathology, including measures of brain connectivity ([@bb0045; @bb0040; @bb0065; @bb0060; @bb0050; @bb0055]). For these initial analyses, however, we aimed to analyze more traditional measures and maps that are perhaps most likely to be used in standardized multi-site DTI analyses, at least in the near future ([@bb9000]).

MRI-based image analysis methods have long been used to track structural atrophy of the aging brain. MRI studies of AD reveal widespread neuronal loss and atrophy in the brain\'s gray matter, especially in medial temporal and hippocampal regions ([@bb0075; @bb0080; @bb0085; @bb0090; @bb0100; @bb0095; @bb0135; @bb0105; @bb0110; @bb0115; @bb0120; @bb0125; @bb0130]). Beta-amyloid and tau proteins accumulate in the brain, leading to inflammation, neuronal atrophy and cell death ([@bb0140; @bb0145]). As neurons are lost, white matter volume is also reduced, due to both myelin degeneration and axon loss in neural fiber tracts ([@bb0150; @bb0155; @bb0160; @bb0165]). Standard anatomical MRI is still the imaging technique most often used in AD studies and clinical trials, but DTI is sensitive to microscopic changes in white matter (WM) integrity not always detectable with standard anatomical MRI ([@bb0170; @bb0175]). Although this is debatable until more evidence is collected, some DTI changes may even precede and predict volume loss ([@bb0180; @bb0040]), making it a potentially beneficial tool for capturing additional or complementary markers of early neurodegeneration. Carriers of some AD risk genes show differences on DTI as young adults, decades before the typical age of onset of AD ([@bb0160]).

Fractional anisotropy (FA) is perhaps the most widely accepted DTI measure and reflects how directionally constrained the diffusion of water is along axons. While higher FA values may imply more coherent or intact axons, or a higher degree of myelination, lower FA may reflect loss of WM integrity and injury. These physiological correlates of the DTI signal are widely accepted, but the differences may have other interpretations, especially where fibers cross ([@bb0185; @bb0190]). Mean diffusivity (MD) captures the average rate of diffusion in all directions, and generally increases with WM injury, especially if normal barriers to diffusion are damaged (such as myelin sheaths on axons). Axial diffusivity (AxD) captures diffusion parallel to axonal fibers, while radial diffusivity (RD) reflects perpendicular diffusion. These measures are linked to axonal injury and demyelination, respectively ([@bb0195; @bb0200]). To date, numerous DTI studies of AD and MCI find that greater cognitive impairment, or poorer diagnosis, is associated with lower FA in the corpus callosum, fornix, cingulum, superior longitudinal fasciculus, and inferior longitudinal fasciculus ([@bb0205; @bb0210; @bb0215; @bb0220]) and DTI measures correlate with widely used clinical or cognitive ratings including the mini-mental state exam (MMSE) ([@bb0225]).

Despite growing diffusion imaging evidence of AD-related WM changes, it is not clear which regions and DTI measures are the most sensitive for detecting diagnostic differences. In order to evaluate the power of drug trial treatment to counteract degeneration, optimizing statistical power for discerning differences and changes is crucial. We focused this current paper on cross-sectional differences in patients and controls, as there are a number of DTI measures, regions, and approaches that need to be compared and ranked in terms of their effect sizes for picking up group differences. We set out to rank the effect sizes for different DTI-based scalar measures in detecting differences in both white matter voxel-based analyses (VBA) and within regions of interest (ROIs). We first examined differences in DTI anisotropy and diffusivity measures, between groups of cognitively healthy normal elderly controls (NC), MCI, and AD patients in both voxel-based and ROI analyses. We also examined the association of anisotropy and diffusivity maps with widely used clinical or cognitive ratings including the MMSE ([@bb0230]), the "sum-of-boxes" clinical dementia rating (CDR-sob) ([@bb0235]), and the Alzheimer\'s Disease Assessment Scale-Cognitive (ADAS-cog) ([@bb0240]). Finally, in a supplementary test, we compared our ROI results to ROIs extracted along the skeleton from the widely used tract-based spatial statistics (TBSS) method ([@bb0245]). Despite the popularity of FA, we hypothesized that we would find the highest effect size and discriminative power for MD measures, as recently suggested in a review of DTI studies of AD by Clerx et al. ([@bb0250]). We also hypothesized that we would find the greatest differences in temporal lobe WM and the corpus callosum (CC), as the temporal lobe is usually the earliest region to be affected by amyloid and tau pathology in AD and DTI studies are often better powered to find group differences in regions such as the CC where fiber coherence is highest.

2. Materials and methods {#s0010}
========================

2.1. Clinical sample and demographics {#s0015}
-------------------------------------

Baseline MRI, DTI, clinical, and neuropsychological data were downloaded from the ADNI database (<http://adni.loni.ucla.edu>). When the analysis was performed (September 2012), data collection for the ADNI2 project was still in progress. Here we performed an initial analysis of 155 participants from 14 data acquisition sites, of whom 44 were normal controls (NC), 88 amnestic MCI subjects, and 23 AD patients (see [Inline Supplementary Table S1](#b0005){ref-type="boxed-text"} for distribution of subjects across sites). Unlike ADNI1, ADNI2 MCI participants include the enrollment of a new early MCI cohort (e-MCI; n = 62), with milder episodic memory impairment than the MCI group of ADNI1. The MCI group of ADNI1 is now referred to as late MCI (l-MCI; n = 26) in ADNI2. Levels of MCI (early or late) were determined using the Wechsler Memory Scale --- Logical Memory II ([@bb0255]). We evaluated the l-MCI and e-MCI groups both separately and as one large MCI group. Detailed inclusion and exclusion criteria are found in the ADNI2 protocol (<http://adni-info.org/Scientists/Pdfs/ADNI2_Protocol_FINAL_20100917.pdf>).

Baseline MRI, DTI, clinical, and neuropsychological data were downloaded from the ADNI database (<http://adni.loni.ucla.edu>). When the analysis was performed (September 2012), data collection for the ADNI2 project was still in progress. Here we performed an initial analysis of 155 participants from 14 data acquisition sites, of whom 44 were normal controls (NC), 88 amnestic MCI subjects, and 23 AD patients (see Inline Supplementary Table S1 for distribution of subjects across sites). Unlike ADNI1, ADNI2 MCI participants include the enrollment of a new early MCI cohort (e-MCI; n = 62), with milder episodic memory impairment than the MCI group of ADNI1. The MCI group of ADNI1 is now referred to as late MCI (l-MCI; n = 26) in ADNI2. Levels of MCI (early or late) were determined using the Wechsler Memory Scale --- Logical Memory II ([@bb0255]). We evaluated the l-MCI and e-MCI groups both separately and as one large MCI group. Detailed inclusion and exclusion criteria are found in the ADNI2 protocol (<http://adni-info.org/Scientists/Pdfs/ADNI2_Protocol_FINAL_20100917.pdf>).

Inline Supplementary Table S1Table S1Distribution of study participants by diagnostic group across each of the 14 acquisition sites. We report the *p*-values from a *χ*^2^ test between the actual and expected distribution of subjects, which we estimated based on the total number of subjects in each diagnostic group, as a proportion of the total, across sites. Although numbers for some sites are small, there is no evidence that any site is enrolling a statistically divergent proportion of subjects in each category.SiteTotalNCMCIAD*χ*^2^*p*-value1169340.74240310.813125610.954143740.9351411210.84680620.817116410.85830300.689145720.9910125520.95111211010.8612110920.8213165921.001484400.85Inline Supplementary Table S1

Inline Supplementary Table S1 can be found online at [http://dx.doi.org/10.1016/j.nicl.2013.07.006](10.1016/j.nicl.2013.07.006){#ir0100}.

Each subject underwent cognitive evaluations. The Mini-Mental State Examination (MMSE) was used to provide a global measure of cognitive status, based on evaluating cognitive domains including orientation to place, orientation to time, registration, attention and concentration, recall, language, and visual construction ([@bb0230]). The total score ranges from 1 to 30, with lower scores indicating impairment. The Clinical Dementia Rating (CDR) was also used as a global measure of dementia severity ([@bb0235]). The "sum-of-boxes" CDR (CDR-sob) score is the sum of 6 measures each assessing the degree of impairment in memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. The CDR-sob score ranges from 0 to 18 (no dementia to severe dementia, respectively). Finally the Alzheimer\'s Disease Assessment Scale-Cognitive (ADAS-cog), a global measure encompassing memory, reasoning, language, orientation, ideational, praxis and constructional praxis ([@bb0240]), was collected where scores range from 0 to 70 (no dementia to severe dementia respectively). In *post-hoc* analyses, we further homed in on specific cognitive domains using the available ADNI composite scores for executive function (ADNI-EF) ([@bb0260]) and memory (ADNI-MEM) ([@bb0265]) derived using data from the ADNI neuropsychological battery. Detailed psychometric calculation protocols are available for download at <https://ida.loni.ucla.edu/>. ADNI-EF was calculated using a combination of WAIS-R Digit Symbol Substitution, Digit Span Backwards, Trails A and B, Category Fluency, and Clock Drawing scores ([@bb0260]) and ADNI-MEM was calculated as a composite of the Rey Auditory Verbal Learning Test (RAVLT), ADAS-Cog, and Logical Memory data ([@bb0265]).

Demographics and diagnostic information for the participants are shown in [Table 1](#t0005){ref-type="table"}. Diagnostic groups did not differ in age, however, education, an AD risk factor ([@bb0270]), was marginally significant between controls and AD. As would be expected, clinical measures that index cognitive decline (MMSE, ADAS-cog, CDR-sob, ADNI-MEM, ADNI-EF) did show significant graded differences between groups.

We further assessed whether these measures revealed more fine-grained differences between the l-MCI and e-MCI subgroups. We found differences in ADAS-cog scores --- a measure developed specifically for Alzheimer\'s disease, and the most widely used primary outcome measure in clinical trials that test AD drug treatment efficacy ([@bb0275]). ADNI-MEM was also significantly different as it is calculated using both ADAS-cog and Logical Memory data, the measure used to initially classify the two MCI subgroups.

2.2. MRI and DTI scanning {#s0020}
-------------------------

All subjects underwent whole-brain MRI scanning on 3 Tesla GE Medical Systems scanners at 14 acquisition sites across North America. Anatomical T1-weighted SPGR (spoiled gradient echo) sequences (256 × 256 matrix; voxel size = 1.2 × 1.0 × 1.0 mm^3^; TI = 400 ms; TR = 6.98 ms; TE = 2.85 ms; flip angle = 11°), and diffusion-weighted images (DWI; 256 × 256 matrix; voxel size: 2.7 × 2.7 × 2.7 mm^3^; TR = 9000 ms; scan time = 9 min; more imaging details can be found at <http://adni.loni.ucla.edu/wp-content/uploads/2010/05/ADNI2_GE_3T_22.0_T2.pdf>) were collected. 46 separate images were acquired for each DTI scan: 5 T2-weighted images with no diffusion sensitization (b~0~ images) and 41 diffusion-weighted images (*b* = 1000 s/mm^2^). This protocol was chosen after conducting a detailed comparison of several different DTI protocols, to optimize the signal-to-noise ratio in a fixed scan time ([@bb0030; @bb0035]). All T1-weighted MR and DWI images were checked visually for quality assurance to exclude scans with excessive motion and/or artifacts; all scans were included.

2.3. Image analysis {#s0025}
-------------------

### 2.3.1. Preprocessing steps {#s0030}

For each subject, all raw DWI volumes were aligned to the average b~0~ image (DTI volume with no diffusion sensitization) using the FSL *eddy_correct* tool ([www.fmrib.ox.ac.uk/fsl](http://www.fmrib.ox.ac.uk/fsl){#ir0115}) to correct for head motion and eddy current distortions. All extra-cerebral tissue was roughly removed from the T1-weighted anatomical scans using a number of software packages, primarily ROBEX, a robust automated brain extraction program trained on manually "skull-stripped" MRI data ([@bb0280]) and FreeSurfer ([@bb0285]). Skull-stripped volumes were visually inspected, and the best one selected and sometimes further manually edited. Anatomical scans subsequently underwent intensity inhomogeneity normalization using the MNI *nu_correct* tool ([www.bic.mni.mcgill.ca/software/](http://www.bic.mni.mcgill.ca/software/){#ir0120}). Non-brain tissue was also removed from the diffusion-weighted images using the Brain Extraction Tool (BET) from FSL ([@bb0290]). To align data from different subjects into the same 3D coordinate space, each T1-weighted anatomical image was linearly aligned to a standard brain template (the downsampled Colin27 ([@bb0295]): 110 × 110 × 110, with 2 mm isotropic voxels) using FSL *flirt* ([@bb0300]) with 6 degrees of freedom (dof) to allow translations and rotations in 3D. To correct for echo-planar imaging (EPI) induced susceptibility artifacts, which can cause distortions at tissue--fluid interfaces, skull-stripped b~0~ images were linearly aligned (FSL *flirt* 9 dof) and then elastically registered to their respective T1-weighted structural scans using an inverse-consistent registration algorithm with a mutual information cost function ([@bb0305]) as described in ([@bb0310]). The resulting 3D deformation fields were then applied to the remaining 41 DWI volumes prior to estimating diffusion parameters. To account for the linear registration of the DWI images to the structural T1-weighted scan, a corrected gradient table was calculated.

### 2.3.2. DTI maps {#s0035}

A single diffusion tensor ([@bb0315]), or ellipsoid, was modeled at each voxel in the brain from the eddy- and EPI-corrected DWI scans using FSL *dtifit*, and scalar anisotropy and diffusivity maps were obtained from the resulting diffusion tensor eigenvalues (λ~1~, λ~2~, λ~3~) which capture the length of the longest, middle, and shortest axes of the ellipsoid. The tensor model in DTI has limitations, especially in regions where fibers cross, but we do not investigate it further here; our other papers consider this in more detail ([@bb0325; @bb0185; @bb0190; @bb0335; @bb0330; @bb0320; @bb0035]). Fractional anisotropy (FA), a measure of the degree of diffusion anisotropy, was calculated from the standard formula:$${FA} = \sqrt{\frac{3}{2}}\frac{\sqrt{\left( {\lambda_{1} - < \lambda >} \right)^{2} + \left( {\lambda_{2} - < \lambda >} \right)^{2} + \left( {\lambda_{3} - < \lambda >} \right)^{2}}}{\sqrt{\lambda_{1}^{2} + \lambda_{2}^{2} + \lambda_{3}^{2}}} \in \left\lbrack 01 \right\rbrack$$$$< \lambda > = \frac{\lambda_{1} + \lambda_{2} + \lambda_{3}}{3}$$- where \<λ\> is the mean diffusivity (MD), or average rate of diffusion in all directions. Axial diffusivity was defined as the primary (largest) eigenvalue (AxD = *λ*~1~), and captures the longitudinal diffusivity, or the diffusivity parallel to axonal fibers (assuming of course that the principal eigenvector is indeed following the dominant fiber direction, which may be unclear in regions with extensive fiber crossing). Radial diffusivity (RD), which captures the average diffusivity perpendicular to axonal fibers, was calculated as the average of the two smaller eigenvalues:$${RD} = \frac{\lambda_{2} + \lambda_{3}}{2}.$$

### 2.3.3. White matter tract atlas ROI summary measures {#s0040}

We linearly, then elastically registered ([@bb0305]) the FA image from the Johns Hopkins University (JHU) DTI atlas ([@bb0340]) to each subject\'s distortion corrected FA image. We then applied that deformation to the stereotaxic JHU "Eve" atlas WM labels (<http://cmrm.med.jhmi.edu/cmrm/atlas/human_data/file/AtlasExplanation2.htm>), using nearest neighbor interpolation to avoid intermixing of labels. This is not the atlas that had the problem pointed out by [@bb0345]. We then superimposed the atlas ROIs into the same coordinate space as our results. We removed 10 ROIs from the analyses (including the left and right middle cerebellar peduncle, pontine crossing tract, medial lemniscus, inferior and superior peduncles) as they often fell partially or completely out of the field-of-view (FOV) of the images. We also excluded the body of the fornix as it is small and prone to misregistration and partial voluming. AD researchers are specifically interested in the fornix as it is the primary posterior pathway coming out of the back of the hippocampus, a key target of pathology. While we included the crus of the fornix/*stria terminalis*, the body is just too small to be resolved well on DTI at this resolution. In addition to the JHU labels, 4 more ROIs were evaluated: bilateral genu, body, and splenium of the corpus callosum (as opposed to just the lateralized measures), as well as the entire corpus callosum, and a large "TOTAL" WM ROI made up of all the other ROIs, to obtain total summary measures of these regions. We were then able to calculate the average FA, MD, RD and AxD, within the boundaries of each of the 43 ROIs for each subject ([Table 2](#t0010){ref-type="table"}).[2](#fn0010){ref-type="fn"}

### 2.3.4. TBSS tract atlas ROI summary measures {#s0045}

Tract-based spatial statistics (TBSS) ([@bb0245]), provided in the FSL software package (<http://www.fmrib.ox.ac.uk/fsl/>), was also performed according to protocols outlined by the ENIGMA-DTI group: <http://enigma.loni.ucla.edu/ongoing/dti-working-group/>. All subjects\' corrected FA maps were linearly, then elastically registered ([@bb0305]) to the ENIGMA-DTI template in ICBM space. The resulting 3D deformation fields were then applied to the three diffusivity maps. All subjects\' spatially normalized FA, MD, RD and AxD data were projected onto the skeletonized ENIGMA-DTI template. Mean anisotropy and diffusivity measures were calculated along the skeleton in the same 43 ROIs ([Table 2](#t0010){ref-type="table"}). This type of analysis has been used previously in both genetic studies and studies of disease to home in on associated WM tracts ([@bb0350; @bb9000]).

### 2.3.5. Template creation and spatial normalization {#s0050}

A study-specific minimal deformation template (MDT) ([@bb0355]) was created using 29 cognitively healthy elderly control (NC) spatially aligned FA maps. An MDT deviates, on average, the least (in some metric) from the anatomy of the subjects, and can often improve registration accuracy and statistical power ([@bb0355; @bb0360]). The MDT was generated by creating an initial affine mean template from all 29 subjects, then registering all the aligned individual scans to that mean using a fluid registration ([@bb0305]) while regularizing the Jacobians ([@bb0365]). A new mean was created from the registered scans; this process was iterated several times. Each subject\'s initial FA map was elastically registered to the final MDT and the resulting deformation fields were applied to the 3 diffusivity maps to align them to the same coordinate space. To ensure white matter alignment across subjects, registered FA maps were thresholded at FA \> 0.2 to include only highly anisotropic anatomy and the thresholded maps were elastically registered to the thresholded MDT (FA \> 0.2). Again, the resulting deformation fields were applied to all previously registered DTI maps. We also used the tissue-specific, smoothing-compensated method (*T-SPOON*) proposed by [@bb0370] to improve tissue specificity and reduce confounds caused by morphometric differences that are not fully corrected by the elastic registration.

2.4. Statistical analysis {#s0055}
-------------------------

We ran voxel-wise multiple linear regressions, covarying for age and sex, to test for statistical effects of AD and MCI diagnosis relative to the NC group, on measures of white matter integrity in FA, MD, RD, and AxD maps. We also tested for associations between these DTI measures and MMSE, CDR-sob, and ADAS-cog scores, controlling for age and sex, across the entire study sample (i.e., including all AD, MCI and NC subjects), and also within each subgroup. We also ran all of the regressions using a random-effects regression model, grouping the data by acquisition site. To limit statistical testing to white matter, where the power is greater to detect differences, statistics were run only on voxels within the boundaries of the MDT thesholded at FA \> 0.2. Prior studies have thresholded FA values between 0.2 and 0.3 to successfully exclude gray matter or CSF ([@bb0375; @bb0245]). As we were studying a clinical population, we chose the more conservative (lower) limit of the recommended FA threshold. We also only ran statistics on voxels of the thresholded MDT present in all subject scans, as some scans had a slightly cropped FOV. As such, we did not consider the inferior parts of the cerebellum and brain stem.

We ran random-effects regressions on the average anisotropy and diffusivity measures within the 43 full ROIs, again covarying for age and sex, testing for statistical effects of diagnosis (NC vs. MCI, or AD), 3 global clinical test scores, and *post-hoc* tests on ADNI-MEM and ADNI-EF. We further tested and compared TBSS ROI measures.

Computing multiple association tests for each ROI, or thousands of tests on a voxel-wise level can introduce a high false positive error rate. To account for these errors, we used the standard false discovery rate (FDR) method to control the false positive rate of each map at *q* = 0.05 ([@bb0380]). All statistical maps shown in this paper ([Figs. 1--5](#f0005 f0010 f0015 f0020 f0025){ref-type="fig"}) were thresholded at the FDR critical *p*-value.

To visualize and compare effect sizes in the anisotropy and diffusivity maps, we computed and graphed the cumulative distribution functions (CDF) of the *p*-values obtained from the voxel-wise and ROI random-effects regressions. The ordered set of observed *p*-values was plotted against the expected null distribution. If there are no group differences (a null distribution), then the plot would fall approximately along the *y* = *x* diagonal line. However, if the CDF initially rises at a rate steeper than 20 times the null CDF (*y* = 20*x*), then the corresponding maps are FDR significant at *q* = 0.05. A greater slope reflects a larger effect size; the FDR critical *p*-value (at *q* = 0.05) is the point at which the curve intersects the *y* = 20*x* line.

DTI measures calculated from a single-tensor diffusion model have limitations in regions with extensive fiber crossing. For example, in AD we might expect FA deficits throughout the brain, but FA may appear to be artificially *increased* where crossing fibers deteriorate ([@bb0385]). To make sure that these results were not false positives we separated the full *p*-value map (irrespective of the significance level of the voxels) into two maps: (1) voxels that showed a negative association, and (2) positively associated voxels. We then independently corrected each *p*-map for multiple statistical comparisons using FDR ([@bb0380]).

As an alternative way to visualize white matter integrity differences between patients and controls, we also created maps showing the "percent difference" in mean DTI measures between AD patients and NC, within the FDR significant regions.$$\mathit{\% Diff} = \frac{\overline{AD} - \overline{NC}}{\overline{NC}}.$$

There is a mild bias in doing this, in that it selects voxels that show effects, and then computes the magnitude of the effects. Even so, it was used to simply describe how much difference was seen in the regions shown, bearing in mind that the same difference would not be found in the rest of the brain.

3. Results {#s0060}
==========

3.1. Voxel-based analyses {#s0065}
-------------------------

### 3.1.1. White matter integrity differences between diagnostic groups {#s0070}

#### 3.1.1.1. AD vs controls {#s0115}

As measured by FA, AD patients showed pervasive deficits in fiber integrity (lower FA) compared to healthy controls, throughout the WM across the entire brain, when using a general linear regression model to adjust for age and sex (critical *p* \< 0.016; 31.9% of voxels survived the FDR threshold ([@bb0380]); minimum *p*-value, 1.65 × 10^− 8^). However, when we used a random-effects regression model at every voxel to take into account acquisition site differences, we found more significant and even more widespread results (critical *p* \< 0.020; 40.1% of voxels survived the FDR threshold ([@bb0380]); minimum *p*-value, 6.66 × 10^− 9^; [Fig. 1](#f0005){ref-type="fig"}a). We therefore proceeded with this model -- fitting a site effect -- for the remainder of the analyses. A few significant voxels exhibited associations in a direction opposite to the great majority of the brain map, and contrary to what would traditionally be accepted as showing impairment. For example, we found regions where the AD group had a higher mean FA ([Fig. 1](#f0005){ref-type="fig"}e; *blue regions*). These regions were largely found at the junction of the corpus callosum commissural fibers and the *corona radiata*. Such regions are notorious for fiber crossings, which may artificially reduce FA, if FA is estimated using the single-tensor diffusion model ([@bb0390]). This pattern has been reported in other AD studies, and may reflect a selective sparing or selective degeneration of one of the pathways in a region with crossing fibers ([@bb0385]). When we separated (and independently FDR-corrected) the map of voxels that showed a negative association with AD and the map of the positively associated voxels, the diffuse negative associations were still significant, but the previously significant positive associations were not.

This pervasive pattern of significance was largely replicated for the three other diffusivity measures. As predicted, we found higher mean RD, AxD and MD values in AD patients relative to controls ([Fig. 1](#f0005){ref-type="fig"} b--d) and the effects were larger and even more diffuse than for FA. CDF plots confirm that FA was not the most sensitive measure for differentiating groups. Comparisons of NC to AD patients ([Fig. 2](#f0010){ref-type="fig"}a) revealed that RD was the most sensitive measure followed closely by MD.

#### 3.1.1.2. Early, late and all MCI vs controls {#s0120}

No significant difference was detected between e-MCI and l-MCI groups for any of the DTI measures, so we first assessed the MCI group as a whole, followed by these subgroups. We found no significant differences between NC and MCI as a whole (n = 88), or NC and the e-MCI (n = 62) subgroup, for any of the anisotropy or diffusivity measures. However, for NC compared to l-MCI subjects (n = 26), we did find significantly higher diffusivity measures in the left hippocampal part of the cingulum (MD: FDR critical *p* \< 3.05 × 10^− 5^; RD: FDR critical *p* \< 2.72 × 10^− 5^; AxD: FDR critical *p* \< 2.46 × 10^− 5^; [Fig. 3](#f0015){ref-type="fig"}). While these measures are significant on their own, the N was small. These contrasts will benefit from further analysis, as the ADNI dataset grows.

### 3.1.2. Correlation with MMSE, CDR-sob, and ADAS-cog neuropsychological scores {#s0075}

#### 3.1.2.1. Full cohort {#s0125}

We first assessed anisotropy and diffusivity map associations with widely used clinical cognitive ratings in the entire study population, including AD patients, MCI, and NC subjects ([Fig. 4](#f0020){ref-type="fig"}). [Fig. 4](#f0020){ref-type="fig"}a shows WM regions where anisotropy and diffusivity differences correlated with the MMSE scores in the entire study population (n = 155). MMSE was significantly positively associated with FA (FDR critical *p* \< 0.018), and negatively associated with diffusivity (MD: FDR critical *p* \< 0.037; RD: FDR critical *p* \< 0.040; AxD: FDR critical *p* \< 0.028). That is, lower FA and higher diffusivity, which typically indicate greater WM deficits, were associated with lower MMSE scores, indicative of greater impairment. [Fig. 4](#f0020){ref-type="fig"}b shows WM regions where FA and diffusivity differences correlated with the CDR-sob scores (n = 155). As expected, FA was negatively associated with CDR-sob (FDR critical *p* \< 0.027), and diffusivity was positively associated (MD: FDR critical *p* \< 0.039; RD: FDR critical *p* \< 0.042; AxD: FDR critical *p* \< 0.029). [Fig. 4](#f0020){ref-type="fig"}c shows WM regions where FA was negatively associated with ADAS-cog (n = 139; FDR critical *p* \< 0.016), and diffusivity positively associated (MD: FDR critical *p* \< 0.040; RD: FDR critical *p* \< 0.041; AxD: FDR critical *p* \< 0.029). Lower FA and higher diffusivity were associated with higher (*worse*) ADAS-cog and CDR-sob scores. CDF plots of MMSE, ADAS-cog, and CDR-sob voxel-wise associations again reveal that FA associations, while FDR significant, show the smallest effect size, while MD and RD have the largest effect sizes ([Fig. 2](#f0010){ref-type="fig"}d).

As with diagnostic group differences, in all clinical score analyses we found small significant regions with associations in a direction opposite to what would traditionally be accepted as showing impairment. Again, when we corrected for multiple comparisons on voxel-wise *p*-maps of each association direction separately, the associations in the unexpected direction were no longer significant and only the intuitive direction remained.

#### 3.1.2.2. Early, late and all MCI {#s0130}

We further assessed associations between cognitive scores and DTI measures in just the MCI group, as well as e-MCI and l-MCI subgroups. We found a significant positive association between all 3 diffusivity measures and CDR-sob within the MCI group (MD: FDR critical *p* \< 0.006; RD: FDR critical *p* \< 0.006; AxD: FDR critical *p* \< 0.002; [Fig. 5](#f0025){ref-type="fig"}) and a small positive association between ADAS-cog and MD in the middle or lateral occipital WM in l-MCI (FDR critical *p* \< 5.35 × 10^− 6^). However, there was no detectable association with anisotropy or diffusivity measures and MMSE scores.

3.2. ROI analyses {#s0080}
-----------------

### 3.2.1. ROI differences between diagnostic groups {#s0085}

#### 3.2.1.1. AD vs controls {#s0135}

We sorted the JHU atlas ROI results by *p*-value to assess which ROIs showed the greatest differences between groups. In doing so, we have to bear in mind that this is not a ranking of the disease effects on the brain by severity; results may also be affected by how accurately each region can be measured, which in turn depends on the size and the homogeneity of the region. With these caveats in mind, [Tables 3--4](#t0015 t0020){ref-type="table"} list the 'top 10' most significant ROIs for each regression analysis (here and in what follows, we use the term 'most significant' to mean lowest *p*-values in the tests of group differences in mean values; we acknowledge that this term is not always preferred by statisticians as the *p*-values from different tests cannot necessarily be compared). When comparing NC to AD patients ([Table 3](#t0015){ref-type="table"}a), the splenium of the corpus callosum, left fornix (*crus*)/*stria terminalis*, left hippocampal part of the cingulum, and total ROI map, were in the top 10 most significant ROIs, across all anisotropy and diffusivity measures. While the superior *corona radiata* and left sagittal stratum (which includes inferior longitudinal fasciculus and inferior fronto-occipital fasciculus) were in the top 10, across all diffusivity measures.

#### 3.2.1.2. Early, late and all MCI {#s0140}

As there were no significant differences between l-MCI and e-MCI subjects across any of the measures, we compared the entire MCI group to NC subjects ([Table 3](#t0015){ref-type="table"}b). While no ROI showed significant FA differences, the splenium of the corpus callosum, left tapetum, left hippocampal part of the cingulum, and left fornix (*crus*)/*stria terminalis* were in the top 10, among all diffusivity measures. We further assessed differences between e-MCI and NC and l-MCI and NC. The left hippocampal part of the cingulum was significant across all three diffusivity measures in both comparisons ([Table 3](#t0015){ref-type="table"}c--d). FA showed no statistically significant differences.

CDF plots of the ROI *p*-values for NC vs AD ([Fig. 2](#f0010){ref-type="fig"}b) confirm VBA findings that FA was the least sensitive measure, and that RD has a slightly higher effect size than other measures. However, CDF plots of the ROI *p*-values, for NC vs MCI, reveal that AxD measures had the largest effect size, followed by MD ([Fig. 2](#f0010){ref-type="fig"}c). [Table 3](#t0015){ref-type="table"}d also reveals that AxD has a larger effect size when comparing l-MCI and NC.

### 3.2.2. ROI correlations with clinical global neuropsychological scores {#s0090}

The strongest associations with MMSE score ([Table 4](#t0020){ref-type="table"}a) across all 4 measures were found in the left hippocampal part of the cingulum, the left fornix (*crus*)/*stria terminalis*, and the total ROI map. All three diffusivity measures were additionally associated with MMSE in the left cingulum, and the bilateral sagittal stratum (this includes the inferior longitudinal fasciculus and inferior fronto-occipital fasciculus).

The strongest associations with CDR-sob score ([Table 4](#t0020){ref-type="table"}b) across all 4 measures were found in the entire corpus callosum, the left hippocampal part of the cingulum, and the total ROI map. All three diffusivity measures additionally associated with CDR-sob in the left cingulum, and bilaterally in the sagittal stratum and inferior fronto-occipital fasciculus.

The strongest associations with the ADAS score ([Table 4](#t0020){ref-type="table"}c) across all 4 measures were found in the left hippocampal part of the cingulum, and in all 3 diffusivity measures in the left cingulum, bilaterally in the sagittal stratum and inferior fronto-occipital fasciculus, and in the total ROI map.

As with voxel-wise measures, we further assessed the association between cognitive scores and ROI DTI measures in just the MCI group as a whole and also in the e-MCI and l-MCI groups separately ([Table 5](#t0025){ref-type="table"}). As would be predicted, we found significant negative MMSE associations with diffusivity in both the MCI group and e-MCI subgroup in the left hippocampal part of the cingulum. We found significant positive associations between MD and AxD and CDR-sob scores in the MCI group and no associations with ADAS-cog.

Again, CDF plots of the ROI *p*-values for cognitive score associations ([Fig. 2](#f0010){ref-type="fig"}b) confirm that FA was the least sensitive measure.

### 3.2.3. ROI analyses summary {#s0095}

Full ROIs that were consistently most significant across all 3 diffusivity measures in more than one analysis ([Fig. 6](#f0030){ref-type="fig"}) included the splenium of the CC, the left cingulum, particularly the hippocampal part, the left fornix (*crus*)/*stria terminalis* which projects to the dorsal region of the hippocampus, bilateral temporal lobe sagittal stratum, and the average measure across all ROIs. They also included the bilateral inferior fronto-occipital fasciculus in clinical score analyses. Of these ROIs, the left fornix (*crus*)/*stria terminalis* and hippocampal cingulum, and total ROI map were most significant across all anisotropy and diffusivity measures in at least two analyses. However, the left hippocampal part of the cingulum was in the top 10 ROIs in by far the most analyses.

For complete tables of TBSS ROI diagnostic group and cognitive score analyses results, please see [Inline Supplementary Tables S2--S4](#b0010 b0015 b0020){ref-type="boxed-text"}. To summarize, TBSS ROIs that were consistently most significant (i.e., giving greatest effect sizes) across all four anisotropy and diffusivity measures in more than one analysis included the splenium of the CC, bilateral hippocampal part of the cingulum, the left sagittal stratum and uncinate, and the average measure across all ROIs ([Inline Supplementary Fig. S1](#b0025){ref-type="boxed-text"}). While full ROI analyses additionally revealed bilateral inferior fronto-occipital fasciculus, left fornix (*crus*)/*stria terminalis*, left cingulum, and right sagittal stratum, as top ROIs and TBSS did not, TBSS ROIs additionally revealed the left uncinate and right hippocampal part of the cingulum. For a comparison of TBSS and full ROI analyses *p*-value CDF plots see [Inline Supplementary Fig. S2](#b0030){ref-type="boxed-text"}.

For complete tables of TBSS ROI diagnostic group and cognitive score analyses results, please see Inline Supplementary Tables S2--S4. To summarize, TBSS ROIs that were consistently most significant (i.e., giving greatest effect sizes) across all four anisotropy and diffusivity measures in more than one analysis included the splenium of the CC, bilateral hippocampal part of the cingulum, the left sagittal stratum and uncinate, and the average measure across all ROIs (Inline Supplementary Fig. S1). While full ROI analyses additionally revealed bilateral inferior fronto-occipital fasciculus, left fornix (*crus*)/*stria terminalis*, left cingulum, and right sagittal stratum, as top ROIs and TBSS did not, TBSS ROIs additionally revealed the left uncinate and right hippocampal part of the cingulum. For a comparison of TBSS and full ROI analyses *p*-value CDF plots see Inline Supplementary Fig. S2.

Inline Supplementary Table S2Table S2Atlas TBSS ROI average anisotropy and diffusivity. While many regions were statistically significant ([@bb0380]), here we highlight regions with the "top 10" significant *p*-values (greatest effect sizes) when comparing mean values between diagnostic groups. We also note the total number of significant ROIs (after FDR correction) out of the 43 tested and the critical FDR *p*-value.FAMDRDA × DROI*p*-ValueROI*p*-ValueROI*p*-ValueROI*p*-Valuea)\
NC\
vs\
ADSCC2.61E− 6CGH L4.68E− 12CGH L4.41E− 12CGH L7.44E− 11CGH L3.89E− 6SS L3.22E− 8SS L1.07E− 7TAP L3.69E− 7Fx/ST L4.76E− 5CGH R1.59E− 7UNC L1.10E− 7CGH R6.30E− 7ACR L1.95E− 4UNC L2.17E− 7CGH R1.79E− 7IFO L7.56E− 7SFO R3.70E− 4SCC2.63E− 7SCC3.32E− 7SS L9.69E− 7Fx/ST R3.81E− 4Fx/ST R4.00E− 7Fx/ST L3.86E− 7SCR L1.15E− 6CC3.90E− 4SFO L8.70E− 7Fx/ST R5.40E− 7UNC L1.27E− 6SS L4.74E− 4TOTAL1.30E− 6SFO L6.21E− 7TOTAL1.36E− 6SFO L5.27E− 4IFO L1.44E− 6TOTAL3.23E− 6SCC2.28E− 6TOTAL6.34E− 4Fx/ST L1.99E− 6SFO R9.86E− 6SFO L2.44E− 6\# sig/4322 (*p* \< 1.99E− 2)41 (*p* \< 4.68E− 2)36 (*p* \< 3.15E− 2)35 (*p* \< 3.94E− 2)b)\
NC\
vs\
MCI----CGH L9.87E− 5CGH L1.12E− 4CGH L3.64E− 4----CGH R8.16E− 4CGH R9.99E− 4CGH R9.53E− 4\# sig/4302 (*p* \< 8.16E− 4)2 (*p* \< 9.99E− 4)2 (*p* \< 9.53E− 4)c)\
NC\
vs\
e-MCI----CGH L8.54E− 4CGH L8.00E− 4RLIC L7.63E− 4----CGH R9.37E− 4CGH R1.46E− 3CGH R1.08E− 3------------CGH L3.32E− 3------------CGC R3.91E− 3\# sig/4302 (*p* \< 9.37E− 4)2 (*p* \< 1.46E− 3)4 (*p* \< 3.91E− 3)d)\
NC\
vs\
l-MCI----CGH L6.54E− 6CGH L1.66E− 5CGH L1.41E− 5\# sig/4301 (*p* \< 6.54E− 6)1 (*p* \< 1.66E− 5)5(*p* \< 1.41E− 5)Inline Supplementary Table S2

Inline Supplementary Table S3Table S3Atlas TBSS ROI average anisotropy and diffusivity. Here we highlight regions with the 10 lowest FDR significant ([@bb0380]) *p*-values (greatest effect sizes) when assessing cognitive test score associations in the entire study population. We also note the total number of significant ROIs (after FDR correction) out of the 43 tested and the critical FDR *p*-value.FAMDRDA × DROI*p*-ValueROI*p*-ValueROI*p*-ValueROI*p*-Valuea) MMSECGH L2.87E− 5CGH L3.12E− 12CGH L1.65E− 12CGH L5.28E− 10CGH R7.55E− 5UNC L8.18E− 9UNC L3.10E− 9UNC L8.36E− 8ACR L1.56E− 4CGH R5.68E− 8CGH R3.37E− 8SS L4.47E− 7ACR R2.46E− 4SS L7.43E− 8SS L9.68E− 7TOTAL8.91E− 7UNC L6.83E− 4TOTAL2.18E− 6ACR L2.96E− 6CGH R1.17E− 6CGC R8.43E− 4CGC L2.60E− 6Fx/ST R3.51E− 6SS R2.69E− 6TOTAL8.48E− 4IFO L3.14E− 6ACR R3.76E− 6SCR L5.88E− 6Fx/ST R9.37E− 4Fx/ST R3.38E− 6CGC L6.53E− 6TAP L6.45E− 6CP R1.01E− 3ACR L5.58E− 6CGC R6.87E− 6IFO L1.90E− 5CC1.24E− 3ACR R6.06E− 6Fx/ST L2.85E− 5CC1.98E− 5\# sig/4322 (*p* \< 2.43E− 2)38 (*p* \< 3.72E− 2)34 (*p* \< 3.22E− 2)35 (*p* \< 3.44E− 2)b) CDR-sobCGH L3.28E− 6CGH L2.86E− 11CGH L6.23E− 12CGH R2.05E− 9CGH R8.87E− 6CGH R3.66E− 11CGH R2.19E− 11CGH L1.20E− 8SCC2.01E− 5SS L1.43E− 7UNC L1.83E− 7TOTAL7.95E− 7CC1.23E− 4UNC L5.52E− 7SS L5.05E− 7SCC8.78E− 7UNC L1.29E− 4SCC6.97E− 7TOTAL2.39E− 6SCR R2.05E− 6TOTAL2.25E− 4TOTAL8.68E− 7SCC2.58E− 6SS R3.65E− 6Fx/ST R4.14E− 4CC3.33E− 6Fx/ST R2.93E− 6SS L3.68E− 6CP L4.25E− 4SS R3.89E− 6ACR L1.13E− 5TAP L4.12E− 6SS L5.32E− 4Fx/ST R4.84E− 6CC1.22E− 5SCR L4.80E− 6GCC6.98E− 4CGC L5.22E− 6CGC R1.71E− 5IFO L4.92E− 6\# sig/4324 (*p* \< 2.36E− 2)38 (*p* \< 2.89E− 2)37 (*p* \< 4.18E− 2)34 (*p* \< 1.48E− 2)c) ADAS-cogCGH L3.39E− 6CGH L4.98E− 13CGH L1.85E− 13CGH L2.01E− 10CGH R4.72E− 4CGH R1.38E− 8CGH R1.47E− 8UNC L8.50E− 8SS L6.63E− 4UNC L3.98E− 8UNC L3.55E− 8CGH R1.68E− 7SCC1.17E− 3SS L8.17E− 8SS L4.98E− 7SS L5.17E− 7ACR R2.21E− 3IFO L1.21E− 6Fx/ST R2.33E− 6TOTAL1.95E− 6Fx/ST R2.79E− 3CGC R1.26E− 6CGC R5.10E− 6SS R3.10E− 6Fx/ST L2.81E− 3Fx/ST R1.70E− 6CGC L1.72E− 5IFO L3.85E− 6CC3.14E− 3SS R2.15E− 6TOTAL2.59E− 5SLF L8.29E− 6TOTAL3.19E− 3CGC L2.47E− 6Fx/ST L4.92E− 5SCC8.48E− 6GCC3.62E− 3TOTAL7.14E− 6SS R5.48E− 5IFO R9.62E− 6\# sig/4316 (*p* \< 1.65E− 2)39 (*p* \< 3.76E− 2)35 (*p* \< 3.210E− 2)35 (*p* \< 1.48E− 2)Inline Supplementary Table S3

Inline Supplementary Table S4Table S4Atlas TBSS ROI average anisotropy and diffusivity. Here we highlight regions with the 10 lowest FDR significant ([@bb0380]) *p*-values (greatest effect sizes) when assessing cognitive test score associations in MCI subjects. We also note the total number of significant ROIs (after FDR correction) out of the 43 tested and the critical FDR *p*-value.FAMDRDA × DROI*p*-ValueROI*p*-ValueROI*p*-ValueROI*p*-ValueCDR-sob\
MCI----SCC9.62E− 4----SCC9.78E− 5----SLF R1.17E− 3----SLF L9.22E− 4----CGC R3.61E− 3----SLF R9.59E− 4----PTR R4.03E− 3----TOTAL1.06E− 3----TOTAL4.53E− 3----PCR R1.89E− 3----SLF L8.51E− 3----SCR R2.23E− 3----SCR R9.19E− 3----PTR R4.29E− 3----CGC L9.49E− 3----SumCC6.19E− 3----PCR R1.09E− 2----PCR L8.46E− 3----CGH R1.17E− 2----SCR L1.03E− 2\# sig/43015 (*p* \< 1.72E− 2)013 (*p* \< 1.38E− 2)Inline Supplementary Table S4

Inline Supplementary Figure S1Fig. S1Of the 43 TBSS ROIs, these 8 ROIs were consistently more sensitive to detecting differences across diffusivity and anisotropy measures in at least two cognitive and/or diagnostic analyses. These graphs show the average FA, MD, RD and AxD in the TBSS ROIs in each diagnostic group. "TOTAL" refers to the ROI generated by combining all the atlas ROIs. Overall, we see a decrease in anisotropy and increase in diffusivity with each stage of the disease.

Inline Supplementary Figure S2Fig. S2Cumulative distribution function (CDF) plots of the distribution of the *p*-values obtained from TBSS and Full ROI linear regression analyses, subjected to multiple comparisons correction using standard FDR ([@bb0380]). If the CDF initially rises at a rate steeper than 20 times the null CDF (y = 20x), then the corresponding maps are declared to be FDR significant at q = 0.05. The larger the deviation is from this line, the greater the effect sizes. (a) NC and AD group comparisons, (b) NC and MCI group comparisons, and (c) clinical cognitive test associations in both full and TBSS ROIs reveal that FA is consistently the least sensitive measure.

Inline Supplementary Tables S2--S4, Figs. S1 and S2 can be found online at [http://dx.doi.org/10.1016/j.nicl.2013.07.006](10.1016/j.nicl.2013.07.006){#ir0145}.

### 3.2.4. Post-hoc ROI correlations with memory and executive function scores {#s0100}

The strongest associations between full ROI measures and ADNI-EF ([Table 6](#t0030){ref-type="table"}a) in the entire study cohort (n = 143) across all four DTI measures were found in the bilateral sagittal stratum and the total ROI map. All three diffusivity measures were additionally associated with ADNI-EF in the bilateral cingulum, left hippocampal cingulum, and left superior longitudinal fasciculus.

There were no associations between FA and ADNI-MEM ([Table 6](#t0030){ref-type="table"}b) in the entire cohort, but all three diffusivity measures were associated with ADNI-MEM bilaterally in the cingulum and hippocampal cingulum, bilateral inferior fronto-occipital fasciculus and sagittal stratum and left uncinate and external capsule.

These measures were not linked to DTI measures in the MCI group as a whole, nor in the e-MCI and l-MCI groups separately.

4. Discussion {#s0105}
=============

In this ADNI study, we found that DTI indicators of white matter impairment have the potential to emerge as useful clinical tools for differentiating diagnostic groups in studies of AD. We had three main findings: (1) in ROI and VBA analyses, we found widespread anisotropy and diffusivity disruptions, often in tracts that pass through the temporal lobe and posterior brain regions (especially the left hippocampal cingulum), in elderly AD and MCI patients; (2) these disruptions were also associated with neuropsychological and cognitive deficits; and (3) diffusivity (MD, RD, AxD) measures were more sensitive for detecting differences than FA measures, and could detect more subtle MCI differences, where FA could not.

Alzheimer\'s disease (AD) is characterized by neuronal loss and widespread gray matter atrophy, but it is also marked by a disturbance in the brain\'s WM pathways, perhaps secondary to the effect of cortical neuronal loss. Changes in white matter neuropathology include partial loss of axons, myelin sheaths, and oligodendroglial cells ([@bb0395; @bb0400]). AD patients have been shown to have significantly more WM hyperintensities (WMH) than controls. WMH are significantly related to cortical atrophy ([@bb0405]) entorhinal cortex ([@bb0410]), and hippocampal atrophy ([@bb0415]) in AD patients. Significant WM atrophy has also been reported ([@bb0420; @bb0425; @bb0430]).

There is growing diffusion imaging evidence of AD related WM changes as well. Most studies report lower FA and higher MD in all lobes of the brain in both MCI and AD when compared to cognitively healthy controls, with emphasis on medial temporal lobe structures ([@bb0435; @bb0225; @bb0440; @bb0445; @bb0450; @bb0455; @bb0170; @bb0460; @bb0465; @bb0470]), consistent with regions showing earliest pathological changes ([@bb0140; @bb0145; @bb0475]) and our results. Many DTI methods have been used to assess WM differences in AD including TBSS ([@bb0245]) and tract or connectivity analyses ([@bb0045; @bb0050; @bb0055]). Here we use the most common methods, VBA and ROI analyses, with ROIs based on a stereotaxic WM ROI atlas ([@bb0340]), which has been shown to accurately parcellate anatomical regions in AD patients with severe atrophy ([@bb0480]). Using predetermined, template-based ROIs can limit findings and registration across subjects may vary due to morphological differences. However, using a common atlas helps to make quantification efficient and easier to standardize across sites ([@bb9000]). Given that VBA findings are diffuse, ROIs are arguably helpful to begin to rank the most sensitive regions for detecting group differences.

When comparing AD patients to NC, the CC splenium, the left fornix (*crus*)/*stria terminalis*, and average measure across all ROIs where in the top 10 most significant (lowest *p*-values) ROIs across all anisotropy and diffusivity measures. However, we found that the most significant ROIs were not necessarily the most coherent tracts. Large clinical DTI studies with limited spatial and directional resolution are often better powered to find deficits in regions where the FA and fiber coherence is highest, such as the splenium of the CC. In a supplementary test, we assessed whether the average of the FA ROI values in the NC group was correlated with the effect size of each ROI (which is related to the *p*-values obtained) in the NC vs AD comparison (see supplementary text). [Inline Supplementary Fig. S3](#b0035){ref-type="boxed-text"} shows that the average FA ROI values in the NC group was not correlated with the effect size (defined by the Z-score corresponding to the *p*-values) of each ROI. VBA revealed similar diffuse patterns, with the largest differences found in the corpus callosum, temporal lobe, cingulum and hippocampal cingulum, and regions near the posterior thalamic radiations. Only diffusivity measures were sensitive enough to detect more subtle differences between MCI groups and NC. The splenium of the corpus callosum, left tapetum, left hippocampal part of the cingulum and left fornix (*crus*)/*stria terminalis* consistently differed in all diffusivity measures but not FA. Only the left hippocampal part of the cingulum was significant across all three diffusivity measures in both comparisons of e-MCI and l-MCI to controls. Similarly, only the left hippocampal part of the cingulum displayed significant increased diffusivity in l-MCI in the VBA analyses.

When comparing AD patients to NC, the largest VBA differences were found in the corpus callosum, temporal lobe, cingulum and hippocampal cingulum, and regions near the posterior thalamic radiations. ROI analyses revealed similar diffuse patterns with the CC splenium, the left fornix (*crus*)/*stria terminalis*, and average measure across all ROIs in the top 10 most significant (lowest p-values) ROIs across all anisotropy and diffusivity measures. However, we found that the most significant ROIs were not necessarily the most coherent tracts. Large clinical DTI studies with limited spatial and directional resolution are often better powered to find deficits in regions where the FA and fiber coherence is highest, such as the splenium of the CC. In a supplementary test, we assessed whether the ROI average FA values in the NC group was correlated with the effect size of each ROI (which is related to the *p*-values obtained) in the NC vs AD comparison (see supplementary text). Inline Supplementary Fig. S3 shows that the ROI average FA values in the NC group were not correlated with the effect size (defined by the Z-score corresponding to the *p*-values) of each ROI.

Only diffusivity measures were sensitive enough to detect more subtle differences between NC and MCI groups. ROIs including the splenium of the corpus callosum, left tapetum, left hippocampal part of the cingulum and left fornix (*crus*)/*stria terminalis* consistently differed in all diffusivity measures but not FA. Only the left hippocampal part of the cingulum was significant across all three diffusivity measures in both comparisons of e-MCI and l-MCI to controls. Similarly, only the left hippocampal part of the cingulum displayed significant increased diffusivity in l-MCI in the VBA analyses.

Inline Supplementary Figure S3Fig. S3Average FA for each ROI across all normal control (NC) participants. ROIs are ordered from those showing the most significant differences (lowest *p*-value) in average FA between AD patients and NC to least significant differences. ROIs that show a significant difference (critical *p* \< 0.023; *shown in green*) are not necessarily those with the highest average FA, compared to the non-significant ROIs (*gray*). In other words, the effect sizes we find are not simply driven by higher FA values or fiber coherence.

Inline Supplementary Fig. S3 can be found online at [http://dx.doi.org/10.1016/j.nicl.2013.07.006](10.1016/j.nicl.2013.07.006){#ir0150}.

The lack of larger differences between the MCI and normal control groups is surprising in light of other studies showing that these groups often differ on other neuroimaging measures. This may be due the small sample size and also heterogeneity in the MCI cohort. The MCI group referred to in papers using ADNI1 data is now called late MCI (l-MCI) in ADNI2. In ADNI2, the majority of the MCI group includes the enrollment of a new cohort called early MCI (e-MCI), with milder episodic memory impairment than the l-MCI group. Among the MCI subjects with DTI data available, a smaller percent will be l-MCI than in phase one of ADNI, perhaps contributing to the apparent discrepancy with other ADNI studies/results. This difference in the ADNI2 versus ADNI1 and other MCI cohorts should be considered in expectations of what the effect sizes should be.

Strongest ROI associations with cognitive scores in the full cohort were consistently found in the left hippocampal part of the cingulum across all anisotropy and diffusivity measures. The total ROI map was also one of the top 10 lowest *p*-values in almost all FA and diffusivity analyses, while left cingulum and bilateral sagittal stratum were in the lowest 10 in all diffusivity analyses. The bilateral inferior fronto-occipital fasciculus was in the lowest 10 in almost all full cohort diffusivity analyses. When it came to picking up subtle differences within the MCI group, CDR-sob scores were most widely correlated with diffusivity in both VBA and ROI analyses. Prior studies also suggest that CDR-sob is a more sensitive clinical assessment than ADAS-cog and MMSE, and it may better relate to measures of atrophy on anatomical MRI ([@bb0485]).

Post-hoc analyses were conducted to assess if there was any association between DTI summary measures and executive function (ADNI-EF) and memory (ADNI-MEM) scores. These analyses revealed some of the strongest associations in temporal lobe tracts that subserve a variety of functions known to deteriorate during aging, including the bilateral sagittal stratum, that carries parts of the inferior fronto-occipital fasciculus and inferior longitudinal fasciculus, the hippocampal cingulum as well as the cingulum. ADNI-EF associations were additionally found in the total ROI and superior longitudinal fasciculus, while ADNI-MEM was associated with DTI measures in the external capsule, inferior fronto-occipital fasciculus and uncinate fasciculus. These regional differences could shed light on the network of brain regions, connected via white matter fiber bundles, involved in each task. Prior DTI studies have linked similar regions to performance in executive function and memory ([@bb0490; @bb0495]).

As patterns of differences were often diffuse across the VBA WM map, the total WM ROI was sometimes one of the 10 lowest *p*-values, but it was never the absolute best. Therefore assessing individual ROIs may offer slightly more power to detect changes than a global summary measure ([@bb9000]). In general, the most significant ROIs were found mainly in the left hemisphere (for example, the left hippocampal part of the cingulum was in the top 10 ROIs in by far the most analyses), which has also been found in some prior MRI and DTI studies ([@bb0505; @bb0515; @bb0510; @bb0085; @bb0520]). A supplementary analysis revealed no evidence of greater variability in ROI measures in the right hemisphere that may be causing the better performance of left hemisphere ROIs (see supplementary text). TBSS ROI results did not differ dramatically from the full average ROI results and left hippocampal cingulum was again 'top 10' in the most analyses; however, it was closely followed by the right hippocampal cingulum.

Aside from the total ROI and bilateral IFO, the ROIs that were consistently significant in at least two analyses ([Fig. 6](#f0030){ref-type="fig"}) corroborate a pattern of degeneration in the temporal lobe and posterior temporo-parietal circuitry found in many other DTI studies of MCI and AD ([@bb0525; @bb0530; @bb0535; @bb0470]); these include limbic tracts in the parahippocampal white matter, posterior cingulum, fornix, and splenium of the CC, and have been linked to lower cognitive scores ([@bb0540; @bb0225; @bb0440; @bb0545; @bb0445; @bb0550; @bb0555; @bb0450; @bb0455; @bb0460; @bb0560; @bb0215]). DTI studies have found lower anisotropy in the white matter pathway of the cingulate gyrus, particularly the posterior cingulum, which connects to the entorhinal cortex and plays a role in the cholinergic system, known to be impaired in AD ([@bb0565; @bb0570; @bb0440; @bb0450; @bb0460]). In fact it has been highly implicated in studies comparing MCI to controls, especially on the left as in our study ([@bb0550; @bb0450; @bb0455; @bb0460; @bb0535]). Cognitive scores like MMSE have also been linked to DTI diffusivity values in the posterior cingulate gyrus in AD ([@bb0545; @bb0550]). Most AD studies also find WM deficits in the corpus callosum, but it is not clear whether the genu is more affected ([@bb0170]), in line with the hypothesis that later maturing regions are the first affected, or the splenium, corroborating a pattern of degeneration in the posterior temporal parietal circuitry ([@bb0440; @bb0450; @bb0555]). A review by [@bb0535] reports that in healthy aging, DTI abnormalities occur in the frontal regions, specifically the frontal white matter, anterior cingulum and the genu of the corpus callosum, while in AD DTI abnormalities are concentrated in the posterior regions. Some studies have dissociated the regional effects of age and dementia, with age effects greater in the anterior corpus callosum and frontal white matter, suggesting an anterior-to-posterior gradient, while individuals with early-stage dementia exhibit minimal additional frontal deficits, but rather show greater white matter deterioration in posterior lobar regions ([@bb0525]).

As in prior studies of aging and AD ([@bb0575; @bb0580]), FA was the *least* sensitive measure when comparing diagnostic groups and cognitive score associations in both ROI and VBA analyses ([Fig. 2](#f0010){ref-type="fig"}). A recent study found that FA measured using TBSS was more strongly associated with spectroscopic measurements than FA measured using voxel-wise averaging which is susceptible to partial-averaging artifacts ([@bb0585]). However, we found that TBSS ROI results were not substantially different from data computed from averaging diffusion indices in ROIs ([Inline Supplementary Fig. S2](#b0030){ref-type="boxed-text"}). A recent AD DTI review -- based on 55 different studies -- noted that MD values have more discriminative power than FA values and higher effect sizes for case--control differences in the frontal, parietal, occipital and temporal lobes ([@bb0250]). To explain age related increases in MD without significant FA changes, [@bb0590] suggested that brain degeneration in aging may be caused, in part, by tissue damage due to processes such as focal ischemia. This may result in lower tissue density, increasing water diffusivity but maintaining underlying directional structure. FA and MD are summary measures based on the ratio and mean of the eigenvalues respectively, but AxD may reflect axonal injury, and RD may reflect demyelination ([@bb0195; @bb0200; @bb0595; @bb0600]). Here, when comparing NC to AD patients in both ROI and VBA analyses, RD was the most strongly associated with WM deficits ([Fig. 2](#f0010){ref-type="fig"}a--b), followed by MD. Increased RD in AD relative to controls, therefore, may reflect demyelination in AD. As in prior studies that reported AxD increases in normal aging and Alzheimer\'s disease ([@bb0445; @bb0575; @bb0580; @bb0605]), we also found higher AxD in MCI, AD, and associated with clinical impairment. In fact, we found slightly larger effect sizes for AxD when comparing CN and l-MCI subjects in the VBA analyses and CN and MCI subjects in the full ROI analyses ([Table 3](#t0015){ref-type="table"}b). Recent longitudinal and cross-sectional studies suggest that AxD might be more sensitive to detecting early changes, while RD becomes progressively better as disease progresses ([@bb0610; @bb0615]). In a study by Bendlin et al. (2012), cerebrospinal fluid biomarkers of AD, T-Tau and Aβ~42~, predicted axial and radial diffusivity, suggesting these CSF biomarkers are potentially related to both neuronal axon integrity and health of oligodendrocyte synthesized myelin. The relationship may have a common cause, if cerebral amyloid and tau burden is related to CSF measures and to axonal loss and poorer myelination. Ultimately, the positive relationships between AD and both AxD and RD may explain why FA, a function of the ratio of these measures, reveals the least differences ([@bb0580]), and could not pick up more subtle deficits in MCI ([Fig. 2](#f0010){ref-type="fig"}b,c; [Table 3](#t0015){ref-type="table"}b--d, [Table 4](#t0020){ref-type="table"}).

As in prior studies of aging and AD ([@bb0575; @bb0580]), FA was the *least* sensitive measure when comparing diagnostic groups and cognitive score associations in both ROI and VBA analyses ([Fig. 2](#f0010){ref-type="fig"}). A recent study found that FA measured using TBSS was more strongly associated with spectroscopic measurements than FA measured using voxel-wise averaging which is susceptible to partial-averaging artifacts ([@bb0585]). However, we found that TBSS ROI results were not substantially different from data computed from averaging diffusion indices in ROIs (Inline Supplementary Fig. S2). A recent AD DTI review -- based on 55 different studies -- noted that MD values have more discriminative power than FA values and higher effect sizes for case--control differences in the frontal, parietal, occipital and temporal lobes ([@bb0250]). To explain age related increases in MD without significant FA changes, [@bb0590] suggested that brain degeneration in aging may be caused, in part, by tissue damage due to processes such as focal ischemia. This may result in lower tissue density, increasing water diffusivity but maintaining underlying directional structure.

FA and MD are summary measures based on the ratio and mean of the eigenvalues respectively, but AxD may reflect axonal injury, and RD may reflect demyelination ([@bb0195; @bb0200; @bb0595; @bb0600]). Here, when comparing NC to AD patients in both ROI and VBA analyses, RD was the most strongly associated with WM deficits ([Fig. 2](#f0010){ref-type="fig"}a--b), followed by MD. Increased RD in AD relative to controls, therefore, may reflect demyelination in AD. As in prior studies that reported AxD increases in normal aging and Alzheimer\'s disease ([@bb0445; @bb0575; @bb0580; @bb0605]), we also found higher AxD in MCI, AD, and associated with clinical impairment. In fact, we found slightly larger effect sizes for AxD when comparing CN and l-MCI subjects in the VBA analyses, and CN and MCI subjects in the full ROI analyses ([Table 3](#t0015){ref-type="table"}b). Recent longitudinal and cross-sectional studies suggest that AxD might be more sensitive to detecting early changes, while RD becomes progressively better as disease progresses ([@bb0610; @bb0615]). Ultimately, the positive relationships between AD and both AxD and RD may explain why FA, a function of the ratio of these measures, reveals the least differences ([@bb0580]), and could not pick up more subtle deficits in MCI ([Fig. 2](#f0010){ref-type="fig"}b,c; [Table 3](#t0015){ref-type="table"}b--d, [Table 4](#t0020){ref-type="table"}).

In addition, a summary measure such as FA, derived from a simple tensor model, may not capture the complexity of white matter architecture. DTI has some limitations in gauging fiber integrity in regions with extensive fiber crossing and mixing. High angular diffusion imaging (HARDI) can better resolve white matter multi-fiber distribution than DTI single-tensor models ([@bb0185; @bb0190]). More sophisticated measures, such as a modified version of FA calculated from the HARDI data "tensor distribution function" (TDF), can better characterize the anisotropy in regions of fiber crossings ([@bb0190]), and may better reveal FA differences that are due to loss in fiber coherence rather than simply partial-volume effects.

Further limitations of this study include the small sample size from each of the 14 sites, and unequal distribution of cases across sites (see [Inline Supplementary Table S1](#b0005){ref-type="boxed-text"}). Despite accounting for site affects using a random effects regression model and grouping the data by acquisition site, some cross-site differences may be unaccounted for in the study design. Additionally we did not adjust for WMH burden, or explore the extent the DTI metrics corresponded with WMH. Finally, the ADNI data set is constantly re-evaluating subject diagnosis, cognitive, and basic demographic data. The data evaluated here was what was available at the time of download and may be changed by ADNI at any time.

Further limitations of this study include the small sample size from each of the 14 sites, and unequal distribution of cases across sites (see Inline Supplementary Table S1). Despite accounting for site effects using a random-effects regression model and grouping the data by acquisition site, some cross-site differences may be unaccounted for in the study design. Additionally we did not adjust for WMH burden, or explore the extent the DTI metrics corresponded with WMH. Finally, the ADNI data set is constantly re-evaluating subject diagnosis, cognitive, and basic demographic data. The data evaluated here was what was available at the time of download and may be modified by ADNI.

5. Conclusion {#s0110}
=============

DTI offers an extensive set of biomarkers for disease detection and monitoring of cognitive decline. We found anisotropy and even more widespread diffusivity disruptions in projection, association, and commissural tracts, particularly in tracts that pass through the temporal lobe and posterior brain regions (especially the left hippocampal cingulum), in elderly AD and MCI patients. These disruptions were associated with neuropsychological and cognitive deficits. As ADNI2 progresses, new subjects are scanned and new measures of WMH are being added to the database. These results should be verified with larger sample sizes and the relationship between DTI based WM disturbances and WMH can be further resolved. Future tract-based connectivity studies may also shed light on how integrity in the tracts affects regional gray matter. We may also be able to create a statistical region-of-interest that may outperform atlas based ROIs ([@bb0165; @bb0625]). ADNI2 is a longitudinal study that will eventually allow us to investigate which of these subjects develop AD, and if these early WM aberrations help predict future deficits and conversion to AD. Future studies combining machine learning methods with different modalities -- including CSF and proteomic markers -- may ultimately determine the best way to distinguish diagnostic groups.

Appendix A. Supplementary data {#s0145}
==============================

Supplementary material.

Data collection and sharing for this project was funded by ADNI (NIH Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer\'s Association; Alzheimer\'s Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health ([www.fnih.org](http://www.fnih.org){#ir0155}). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer\'s Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. Algorithm development for this study was also funded by the NIA, NIBIB, the National Library of Medicine, and the National Center for Research Resources (AG016570, EB01651, LM05639, RR019771 to PT). Investigators within ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. For a complete listing of ADNI investigators, please see: <http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf>.
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Except for the total WM ROI, all these ROI measures for all subjects are available for download at <https://ida.loni.ucla.edu/>.

![(Top panels) Statistical maps show − log~10~*p*-values within regions where AD patients exhibit significantly *higher* (a) MD (FDR critical *p* \< 0.038), (b) RD (FDR critical *p* \< 0.041), and (c) AxD (FDR critical *p* \< 0.027) than healthy controls (NC). The cingulum, temporal lobe (including the hippocampal part of the cingulum) and splenium of the corpus callosum show the "most significant" differences, i.e. greatest effect sizes in the maps. (d) Significant but slightly less profuse FA differences between groups were also found (FDR critical *p* \< 0.020). (e) *Beta*-values (non-normalized slope of the regression) within FDR significant regions largely revealed regions with *lower* FA in AD, but there are small regions, notorious for crossing fibers, where AD patients have higher mean FA than controls (*dark blue*), contrary to what would traditionally be accepted as showing impairment. (Bottom panel) Maps show the *percent difference* in FA and diffusivity measures between AD patients and NC within FDR significant regions. Again, the corpus callosum, temporal lobe, cingulum (including the hippocampal part of the cingulum), and the posterior thalamic radiations show the greatest degree of difference (up to \~ 33%); we note that the significance values and effect sizes in these regions depend on the mean group differences and its standard error, which is more completely reflected in top panels. In both figures, MD and RD differences are greater and more widespread. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr1){#f0005}

![Effect sizes for FA, MD, RD and AxD measures in AD, MCI and NC group comparisons and clinical cognitive test associations reveal that FA is consistently the least sensitive measure. This type of plot is used to compare effect sizes in statistical maps based on different diffusivity measures. We used it to help decide which DTI measures best distinguish the diagnostic groups. Here we show cumulative distribution function (CDF) plots of the distribution of the *p*-values obtained from (a,d) voxel-wise and (b--c) ROI linear regressions, which are subjected to multiple comparisons correction using standard FDR ([@bb0380]). (a) VBA comparisons of NC to AD patients revealed that RD was the most sensitive measure (denoted by the higher critical *p*-values controlling the FDR/the highest non-zero *x*-coordinate where the CDF crosses the *y* = 20*x* line) followed closely by MD. (b) ROI comparisons of NC vs AD confirm that FA was the *least sensitive* measure. (c) ROI comparisons of NC vs MCI reveal that AxD measures had the largest effect size, followed by MD (VBA comparisons were not significant). (d) Voxel-wise and (e) ROI linear regressions on associations between cognitive scores (MMSE, CDR-sob, and ADAS-cog) in the entire cohort and anisotropy and diffusivity measures confirm that FA associations, while FDR significant, show the smallest effect size, while MD and RD have the largest effect sizes.](gr2){#f0010}

![Statistical maps show the − log~10~*p*-values within regions where l-MCI subjects exhibit significantly *higher* AxD (FDR critical *p* \< 2.46 × 10^− 5^) than healthy controls (NC). The left hippocampal part of the cingulum was also significant in MD and RD maps. This region is small, but it passes the conventional FDR correction for multiple comparisons, and is in a region implicated in early changes in AD (medial temporal regions). With a greater sample size, this effect may be detectable in the other hemisphere as well.](gr3){#f0015}

![Statistical maps show that clinical scores on the (a) MMSE, (b) CDR-sob, and (c) ADAS-cog are related to detectable differences in fractional anisotropy, and mean, radial and axial diffusivity in the entire cohort. These maps show the − log~10~*p*-values within regions that significantly correlate with cognitive scores. RD and MD show the most widespread and robust associations. The hippocampal part of the cingulum and surrounding temporal lobes show the "most significant" associations (i.e., lowest *p*-values and highest voxel-wise effect sizes) between cognitive performance and white matter integrity.](gr4){#f0020}

![Statistical maps show where CDR-sob scores are significantly positively associated with diffusivity measures in the MCI group, considered on its own (n = 88). Higher diffusivity, indicative of greater WM deficits, is associated with greater CDR-sob scores indicative of greater impairment. We find the "most significant" association (i.e., strongest voxel-wise effect) in the splenium of the corpus callosum and the posterior cingulum.](gr5){#f0025}

![Of the 43 full ROIs, these 9 ROIs were consistently more sensitive to detecting differences across diffusivity and anisotropy measures in at least two cognitive and/or diagnostic analyses. These graphs show the average FA, MD, RD and AxD in the ROIs in each diagnostic group. "TOTAL" refers to the ROI generated by combining all the atlas ROIs. Overall, we see a decrease in anisotropy and increase in diffusivity with each stage of the disease.](gr6){#f0030}

###### 

Demographics and clinical scores for the participants.

                                              NC            MCI           e-MCI         l-MCI           AD              *p*-value for group difference                                  
  ------------------------------------------- ------------- ------------- ------------- --------------- --------------- -------------------------------- --------------- -------------- ---------------
  Age                                         72.7 ± 5.9    73.3 ± 7.3    74.0 ± 7.9    71.8 ± 5.3      75.8 ± 10.0     0.59                             0.27            0.15           0.17
  Sex                                         22 M/22 F     53 M/35 F     38 M/24 F     15 M/11 F       15 M/8 F        --                               --              --             --
  Education                                   16.6 ± 2.7    15.9 ± 2.7    15.8 ± 2.8    16.2 ± 2.5      15.0 ± 3.0      0.18                             0.22            0.50           0.05
  MMSE                                        28.9 ± 1.3    27.8 ± 1.6    28.0 ± 1.5    27.5 ± 1.8      23.0 ± 1.9      **1.01E− 4**                     **4.90E− 12**   0.24           **1.57E− 14**
  ADAS-cog[a](#tf0005){ref-type="table-fn"}   5.3 ± 2.9     9.6 ± 4.2     8.4 ± 3.7     12.7 ± 4.0      20.4 ± 7.3      **2.90E− 9**                     **2.04E− 6**    **1.45E− 4**   **1.04E− 8**
  CDR-sob                                     0.03 ± 0.1    1.3 ± 0.7     1.2 ± 0.6     1.4 ± 0.9       4.96 ± 1.4      **1.38E− 27**                    **2.69E− 12**   0.27           **2.68E− 14**
  ADNI-MEM[b](#tf0010){ref-type="table-fn"}   0.84 ± 0.52   0.22 ± 0.46   0.36 ± 0.42   − 0.12 ± 0.38   − 0.74 ± 0.68   **1.01E− 8**                     **4.14E− 6**    **5.97E− 6**   **3.64E− 10**
  ADNI-EF[b](#tf0010){ref-type="table-fn"}    0.79 ± 0.74   0.16 ± 0.64   0.14 ± 0.61   0.19 ± 0.73     − 0.86 ± 0.87   **1.65E− 5**                     **5.16E− 5**    0.75           **2.51E− 8**

Bold signifies significant (i.e. p \< 0.05).

ADAS-cog data were available only for a subset of the subjects, with the following numerical breakdown: NC n = 41, MCI n = 78 (e-MCI = 57, l-MCI = 21), AD n = 20.

ADNI-MEM and ADNI-EF composite scores were available only for a subset of the subjects, with the following numerical breakdown: NC n = 41, MCI n = 82 (e-MCI = 58, l-MCI = 24), AD n = 20.

###### 

Index of 43 ROIs from the WM tract atlas ([@bb0340]) followed by their abbreviations.

  ------------------------------------------ ---------- -------------------------------------- -----------
  Genu of corpus callosum                    GCC        Posterior thalamic radiation           PTR L,R
  Body of corpus callosum                    BCC        Sagittal stratum                       SS L,R
  Splenium of corpus callosum                SCC        External capsule                       EC L,R
  Full corpus callosum                       CC         Cingulum (cingulate gyrus)             CGC L,R
  Corticospinal tract                        CST L,R    Cingulum (hippocampus)                 CGH L,R
  Cerebral peduncle                          CP L,R     Fornix (*crus*)/*Stria terminalis*     FX/ST L,R
  Anterior limb of internal capsule          ALIC L,R   Superior longitudinal fasciculus       SLF L,R
  Posterior limb of internal capsule         PLIC L,R   Superior fronto-occipital fasciculus   SFO L,R
  Retrolenticular part of internal capsule   RLIC L,R   Inferior fronto-occipital fasciculus   IFO L,R
  Anterior *corona radiata*                  ACR L,R    Uncinate fasciculus                    UNC L,R
  Superior *corona radiata*                  SCR L,R    *Tapetum*                              TAP L,R
  Posterior *corona radiata*                 PCR L,R    All ROIs                               TOTAL
  ------------------------------------------ ---------- -------------------------------------- -----------

###### 

Atlas ROI average anisotropy and diffusivity. While many regions were statistically significant ([@bb0380]), here we highlight regions with the "top 10" significant *p*-values (greatest effect sizes) when comparing mean values between diagnostic groups (in the left column we show the diagnostic groups being compared). We also note the total number of significant ROIs (after FDR correction) out of the 43 tested and the critical FDR *p*-value.

  ------------------------------------------------------------------------------------------------------------------------------------------------------
              FA                     MD                     RD                     AxD                                                       
  ----------- ---------------------- ---------------------- ---------------------- ---------------------- ----------- ----------- ---------- -----------
  a)\         Fx/ST L                1.44E− 7               SS L                   2.09E− 11              SS L        6.19E− 11   SS L       6.29E− 11
  NC\                                                                                                                                        
  vs\                                                                                                                                        
  AD                                                                                                                                         

  SCC         1.40E− 6               CGH L                  1.23E− 9               CGH L                  1.69E− 09   CGH L       1.68E− 9   

  TAP L       2.46E− 6               TOTAL                  4.63E− 9               TOTAL                  6.89E− 09   TOTAL       7.47E− 9   

  PTR L       2.07E− 5               SCR L                  1.11E− 8               SCR L                  6.22E− 08   SCR L       1.74E− 8   

  CC          4.41E− 5               SCC                    6.54E− 8               PTR L                  7.64E− 08   IFO L       3.04E− 8   

  SFO R       5.86E− 5               Fx/ST L                1.07E− 7               Fx/ST L                7.70E− 08   SS R        9.02E− 8   

  TAP R       8.79E− 5               PTR L                  1.10E− 7               SCC                    8.05E− 08   Fx/ST L     2.54E− 7   

  ACR L       1.35E− 4               SS R                   1.24E− 7               TAP L                  1.25E− 07   EC L        3.21E− 7   

  TOTAL       1.62E− 4               TAP L                  1.43E− 7               ACR L                  1.40E− 07   SCC         3.34E− 7   

  CGH L       1.84E− 4               IFO L                  2.77E− 7               SCR R                  2.82E− 07   UNC L       3.46E− 7   

  \# sig/43   24 (*p* \< 2.32E− 2)   42 (*p* \< 2.54E− 2)   42 (*p* \< 2.72E− 2)   41 (*p* \< 4.23E− 2)                                      

                                                                                                                                             

                                                                                                                                             

  b)\         --                     --                     CGH L                  5.65E− 5               CGH L       8.47E− 5    CGH L      6.91E− 5
  NC\                                                                                                                                        
  vs\                                                                                                                                        
  MCI                                                                                                                                        

  --          --                     SCC                    2.60E− 3               SCC                    3.23E− 3    SS L        3.18E− 3   

  --          --                     Fx/ST L                4.39E− 3               Fx/ST L                3.89E− 3    SCC         3.65E− 3   

  --          --                     TAP L                  5.14E− 3               TAP L                  4.48E− 3    Fx/ST L     6.06E− 3   

  --          --                     SS L                   5.48E− 3               --                     --          TOTAL       6.14E− 3   

  --          --                     --                     --                     --                     --          SS R        6.92E− 3   

  --          --                     --                     --                     --                     --          PTR L       7.20E− 3   

  --          --                     --                     --                     --                     --          SCR L       8.80E− 3   

  --          --                     --                     --                     --                     --          TAP L       8.86E− 3   

  --          --                     --                     --                     --                     --          EC R        1.01E− 2   

  \# sig/43   0                      5 (*p* \< 5.47E− 3)    4 (*p* \< 4.48E− 3)    12 (*p* \< 1.23E− 2)                                      

                                                                                                                                             

                                                                                                                                             

  c)\         --                     --                     CGH L                  6.16E− 4               CGH L       7.33E− 4    CGH L      8.92E− 4
  NC\                                                                                                                                        
  vs\                                                                                                                                        
  e-MCI                                                                                                                                      

  --          --                     SCR L                  3.18E− 3               --                     --          --          --         

  --          --                     SCC                    3.35E− 3               --                     --          --          --         

  \# sig/43   0                      3 (*p* \< 3.35E− 3)    1 (*p* \< 7.33E− 4)    1 (*p* \< 8.92E− 4)                                       

                                                                                                                                             

                                                                                                                                             

  d)\         --                     --                     CGH L                  4.71E− 5               CGH L       9.53E− 5    CGH L      3.01E− 5
  NC\                                                                                                                                        
  vs\                                                                                                                                        
  l-MCI                                                                                                                                      

  --          --                     --                     --                     --                     --          SS L        1.88E− 4   

  --          --                     --                     --                     --                     --          SS R        1.47E− 3   

  --          --                     --                     --                     --                     --          Fx/ST L     5.38E− 3   

  --          --                     --                     --                     --                     --          PTR L       5.68E− 3   

  \# sig/43   0                      1 (*p* \< 4.71E− 5)    1 (*p* \< 9.53E− 5)    5 (*p* \< 5.678E− 3)                                      
  ------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Atlas ROI average anisotropy and diffusivity. Here we highlight regions with the 10 lowest FDR significant ([@bb0380]) *p*-values (greatest effect sizes) when assessing cognitive test score associations in the entire study population. We also note the total number of significant ROIs (after FDR correction) out of the 43 tested and the critical FDR *p*-value.

                 FA                     MD                     RD                     AxD                                                        
  -------------- ---------------------- ---------------------- ---------------------- ---------------------- ----------- ----------- ----------- -----------
  a\) MMSE       Fx/ST L                3.14E− 5               CGH L                  8.01E− 15              CGH L       1.96E− 14   CGH L       1.96E− 14
  PTR L          2.11E− 4               CGC L                  2.05E− 8               SS L                   5.86E− 8    SS R        4.47E− 8    
  ACR L          2.13E− 4               SS L                   2.98E− 8               CGC L                  9.93E− 8    SS L        6.95E− 8    
  ACR R          3.60E− 4               ACR L                  1.57E− 7               ACR L                  1.22E− 7    TOTAL       1.23E− 7    
  TOTAL          5.95E− 4               SS R                   1.83E− 7               TOTAL                  5.06E− 7    UNC L       1.67E− 7    
  SCC            6.18E− 4               TOTAL                  2.46E− 7               ACR R                  7.63E− 7    CGC L       3.61E− 7    
  CC             7.59E− 4               IFO L                  3.99E− 7               SS R                   9.68E− 7    EC L        4.56E− 7    
  CP R           1.27E− 3               Fx/ST L                9.60E− 7               IFO L                  1.17E− 6    Fx/ST L     6.33E− 7    
  CGH L          1.42E− 3               ACR R                  1.17E− 6               Fx/ST L                1.28E− 6    CGH R       1.42E− 6    
  BCC            1.46E− 3               CGH R                  1.32E− 6               IFO R                  1.91E− 6    RLIC L      2.04E− 6    
  \# sig/43      24 (*p* \< 2.78E− 2)   43 (*p* \< 1.76E− 2)   43 (*p* \< 3.66E− 2)   42 (*p* \< 2.37E− 2)                                       
                                                                                                                                                 
                                                                                                                                                 
  b\) CDR-sob    SCC                    1.02E− 5               CGH L                  2.21E− 12              CGH L       2.34E− 12   CGH L       1.47E− 11
  CC             1.38E− 5               IFO R                  1.06E− 9               IFO R                  4.29E− 9    SS L        4.52E− 9    
  PTR L          4.49E− 5               SS L                   2.96E− 9               SS L                   9.54E− 9    SS R        9.72E− 9    
  GCC            8.80E− 5               IFO L                  6.57E− 9               IFO L                  1.98E− 8    IFO R       1.36E− 8    
  TOTAL          9.75E− 5               CGC L                  9.75E− 9               TOTAL                  6.20E− 8    TOTAL       3.48E− 8    
  BCC            1.09E− 4               SS R                   3.75E− 8               CGC L                  6.69E− 8    IFO L       5.56E− 8    
  Fx/ST L        1.28E− 4               TOTAL                  3.80E− 8               ACR L                  1.10E− 7    CGC L       9.34E− 8    
  TAP L          2.17E− 4               ACR L                  1.44E− 7               SS R                   2.16E− 7    CC          2.57E− 7    
  CGH L          2.75E− 4               CC                     1.48E− 7               CC                     2.68E− 7    PCR L       2.79E− 7    
  ACR L          4.61E− 4               SCR L                  2.23E− 7               SCR L                  4.76E− 7    UNC L       4.09E− 7    
  \# sig/43      25 (*p* \< 2.71E− 2)   42 (*p* \< 3.59E− 2)   42 (*p* \< 2.83E− 2)   40 (*p* \< 4.22E− 2)                                       
                                                                                                                                                 
                                                                                                                                                 
  c\) ADAS-cog   CGH L                  1.68E− 4               CGH L                  3.26E− 12              CGH L       2.14E− 12   CGH L       6.56E− 11
  PTR L          4.28E− 4               SS L                   2.09E− 10              SS L                   5.39E− 10   SS L        4.55E− 10   
  SCC            6.74E− 4               SS R                   3.16E− 9               SS R                   2.43E− 8    SS R        6.36E− 10   
  Fx/ST L        8.57E− 4               IFO R                  1.91E− 8               IFO R                  1.09E− 7    EC L        3.63E− 8    
  GCC            1.32E− 3               IFO L                  8.13E− 8               IFO L                  6.38E− 7    IFO R       1.19E− 7    
  CC             1.71E− 3               CGC L                  1.24E− 7               CGC L                  7.75E− 7    TOTAL       2.01E− 7    
  SFO R          1.74E− 3               TOTAL                  5.02E− 7               TOTAL                  1.30E− 6    IFO L       2.99E− 7    
  ACR R          1.75E− 3               EC L                   2.49E− 6               ACR R                  3.45E− 6    CGC L       6.08E− 7    
  PTR R          3.29E− 3               CGC R                  3.61E− 6               PTR L                  1.06E− 5    UNC L       8.48E− 7    
  TAP L          3.35E− 3               ACR R                  5.54E− 6               ACR L                  1.36E− 5    SLF L       9.20E− 7    
  \# sig/43      17 (*p* \< 1.8E− 2)    41 (*p* \< 3.62E− 2)   41 (*p* \< 4.70E− 2)   39 (*p* \< 3.80E− 2)                                       

###### 

Atlas ROI average anisotropy and diffusivity. Here we highlight regions with the "top 10" FDR significant ([@bb0380]) *p*-values (greatest effect sizes) when assessing cognitive test score associations within diagnostic subgroups. We also note the total number of significant ROIs (after FDR correction) out of the 43 tested and the critical FDR *p*-value.

  ---------------------------------------------------------------------------------------------------------------------------
              FA   MD                    RD                    AxD                                                 
  ----------- ---- --------------------- --------------------- --------------------- ------- ---------- ---------- ----------
  MMSE\       --   --                    CGH L                 2.65E− 6              CGH L   5.02E− 6   CGH L      3.50E− 6
  MCI                                                                                                              

  \# sig/43   0    1 (*p* \< 2.65E− 6)   1 (*p* \< 5.02E− 6)   1 (*p* \< 3.50E− 6)                                 

                                                                                                                   

  MMSE\       --   --                    CGH L                 9.37E− 5              CGH L   1.52E− 4   CGH L      1.03E− 4
  e-MCI                                                                                                            

  \# sig/43   0    1 (*p* \< 9.37E− 5)   1 (*p* \< 1.52E− 4)   1 (*p* \< 1.03E− 4)                                 

                                                                                                                   

                                                                                                                   

  CDR-sob\    --   --                    SLF R                 4.15E− 4              --      --         SLF R      6.94E− 5
  MCI                                                                                                              

  --          --   --                    --                    --                    --      SLF L      2.98E− 4   

  --          --   --                    --                    --                    --      PCR R      1.03E− 3   

  --          --   --                    --                    --                    --      SCC        1.64E− 3   

  --          --   --                    --                    --                    --      CGC L      3.46E− 3   

  \# sig/43   0    1 (*p* \< 4.15E− 4)   0                     5 (*p* \< 3.46E− 3)                                 
  ---------------------------------------------------------------------------------------------------------------------------

###### 

Cognitive correlates of the average anisotropy and diffusivity in different atlas regions of interest. Here we highlight regions with the "top 10" FDR significant ([@bb0380]) *p*-values (greatest effect sizes) when assessing executive function (ADNI-EF) and memory (ADNI-MEM) composite neuropsychological score associations in the entire study population. We also note the total number of significant ROIs (after FDR correction) out of the 43 tested and the critical FDR *p*-value.

                 FA                     MD                     RD                     AxD                                                      
  -------------- ---------------------- ---------------------- ---------------------- ---------------------- ---------- ----------- ---------- ----------
  a\) ADNI-EF    SS L                   5.77E− 5               SS L                   1.85E− 9               SS L       9.15E− 10   SS L       4.21E− 8
  TOTAL          1.38E− 4               SS R                   8.12E− 9               SS R                   8.81E− 9   SS R        4.78E− 8   
  GCC            2.46E− 4               CGC L                  4.68E− 8               CGC L                  1.39E− 7   CGC L       1.55E− 6   
  SS R           3.42E− 4               CGC R                  3.10E− 7               CGH L                  3.29E− 7   CGC R       1.75E− 6   
  PTR R          4.33E− 4               CGH L                  6.04E− 7               CGC R                  1.62E− 6   RLIC L      2.17E− 6   
  ACR L          4.66E− 4               RLIC L                 1.46E− 6               TOTAL                  1.63E− 6   TOTAL       4.02E− 6   
  CC             4.83E− 4               TOTAL                  1.61E− 6               IFO R                  7.14E− 6   CGH L       5.08E− 6   
  Fx/ST L        7.55E− 4               IFO R                  3.31E− 6               ACR L                  9.49E− 6   EC L        5.85E− 6   
  PTR L          7.90E− 4               SLF L                  4.27E− 6               ACR R                  1.08E− 5   SCC         7.35E− 6   
  SCC            8.84E− 4               EC L                   8.76E− 6               SLF L                  1.85E− 5   SLF L       1.21E− 5   
  \# sig/43      28 (*p* \< 2.39E− 2)   43 (*p* \< 3.24E− 2)   43 (*p* \< 3.27E− 2)   41 (*p* \< 3.49E− 2)                                     
                                                                                                                                               
                                                                                                                                               
  b\) ADNI-MEM   --                     --                     CGH L                  1.38E− 9               CGH L      1.68E− 9    CGH L      5.28E− 9
  --             --                     SS L                   4.70E− 8               SS L                   1.26E− 7   SS L        7.59E− 8   
  --             --                     CGC L                  4.14E− 7               IFO R                  2.41E− 6   CGC L       2.88E− 7   
  --             --                     IFO R                  5.05E− 7               CGC L                  4.24E− 6   SS R        4.83E− 7   
  --             --                     IFO L                  1.03E− 6               IFO L                  8.30E− 6   EC L        8.94E− 7   
  --             --                     SS R                   2.21E− 6               SS R                   9.67E− 6   IFO R       1.40E− 6   
  --             --                     CGC R                  4.87E− 6               CGC R                  3.68E− 5   IFO L       1.44E− 6   
  --             --                     EC L                   2.14E− 5               EC L                   2.22E− 4   CGC R       3.15E− 6   
  --             --                     CGH R                  1.33E− 4               CGH R                  3.36E− 4   UNC L       4.44E− 5   
  --             --                     UNC L                  1.65E− 4               UNC L                  3.69E− 4   CGH R       5.00E− 5   
  \# sig/43      0                      35 (*p* \< 3.06E− 2)   33 (*p* \< 3.35E− 2)   35 (*p* \< 3.51E− 2)                                     

[^1]: Many investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data, but most of them did not participate in the analysis or writing of this report. A complete list of ADNI investigators may be found at: <http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf>.
